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Polycyclic structures fused at a central carbon are of great interest due to their appealing
conformational features and their structural implications in biological systems. Although progress in
the development of synthetic methodologies towards such structures has been impressive, the
stereoselective construction of such quaternary stereocentres remains a significant challenge in the total
synthesis of natural products. This review highlights the progress in the formation of 1-
oxaspiro[4.n]alkan-2-ones (2 # n # 7) with concomitant formation of the quaternary spiro centre.
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1 Introduction
Spirolactones containing natural products represent a large
class of structurally diverse molecules exhibiting a wide range
of biological activities. Key examples include: drospirenone
(Fig. 1), a synthetic progestin that is a component of certain
birth control formulations such as Yasmin 28! (marketed by
Bayer Schering Pharma),1 the world’s most popular con-
traceptive pill, ranked in the top 200 brand-name drugs by retail
dollars in 2008;2 and abyssomicin C, a potent antibacterial
agent against Gram-positive bacteria, including resistant
Staphylococcus aureus strains (MIC for a methicillin-resistant
strain ¼ 4 mg mL"1; MiC for a vancomycin-resistant strain ¼
13 mg mL"1).3
The stereoselective synthesis of spirolactones is a challenging
task, requiring control in the construction of the quaternary
carbon.4 The presence of the sterically constrained spiro struc-
ture in various natural products of biological importance also
adds to the interest in investigations of spiro compounds. Most
of the methods to access spirolactones involve an intramolecular
esterification reaction, which is favoured for entropic reasons.
A number of natural products have been obtained by this
approach (e.g. arteannuine,5 norsecurinine,6 secu’amanine,7
Fig. 1
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stemonamide8). Since this strategy requires the prior installation
of the tertiary alcohol, these methods will not be covered within
this review. Instead, we will focus on transformations involving
the creation of the spirolactone concomitant to cyclisation with
the fused stereocentre – potentially powerful synthetic
transformations allowing the formation of a quaternary stereo-
centre (still one of the most challenging tasks in organic
synthesis).
Herein, we will cover the synthesis of spirobutenolides and
more specifically the 1-oxaspiro[4.n]alkan-2-ones (2 # n # 7)
(Fig. 2).
This review will discuss different methods to create simulta-
neously the spirolactone and the quaternary spiro stereocentre
and their application to the synthesis of natural products.
This will be divided either into categories of reaction or species
used: oxidation, reduction, radicals, dienolate, cationic rear-
rangement, organometallic derivatives, halolactonisation, peri-
cyclic reactions.
Spirocyclic structures have already been the subject of
a number of reviews,9,10 including those devoted to spiroketals11
and spirocyclic ethers,12 and the reader is directed to these articles
for discussion of these topics.
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2 Oxidation: dearomatisation of phenol to quinone
The prevalence of p-spiroquinones in natural products, biologi-
cally active molecules and ligands underscores the importance of
devising general methods for their efficient construction.
Quinones are commonly prepared by chemical oxidation,13
electrochemical oxidation14 or monohydrolysis of the corre-
sponding quinone bisacetals. Phenolic oxidation has often been
implicated as the pivotal step in the biosynthesis of natural
product incorporating a p-spiroquinone moiety.
In 1987, Tamura15 reported an iodine(III)-induced dearomati-
sation of phenols to quinones. Later on Kobayashi described
a novel cerium(IV)-mediated oxidative coupling of 2,6-dibromo-
phenol derivatives.16 Both these methods have been used exten-
sively in spirolactone synthesis.
2.1 Hypervalent iodine(III)
In a typical procedure, a solution of p-phenol 1 in anhydrous
acetonitrile was treated with bis(trifluoroacetoxy)-iodobenzene
(BTIB) in presence of pyridine (Scheme 1). After oxidation of
this phenol ring to the corresponding quinone, intramolecular
ipso-trapping by the carboxy nucleophile took place, leading to
the spiro compound 2 in 86% yield.
Later on, Hara17 described a one-pot procedure utilising
bis(acetoxy)-iodobenzene (BAIB) followed by an aqueous
sodium chloride or bromide quench to access dihalodienone
spirolactone 5 from phenol 3 (Scheme 2). Three equivalents of
BAIB were required, but this reagent is much less expensive than
the previously used BTIB. This domino process allowed the
formation of three new s-bonds together with a stereogenic
quaternary centre.
This methodology was next extended to a domino reaction
featuring the Wessely-type intramolecular oxidation18 followed
by an intermolecular Diels–Alder reaction (Scheme 3).19 Unlike
previously reported examples, phenol 6 bears the carboxylic acid
suitably tethered at the ortho position. An additional functional
group para to the alcohol circumvents any trapping at that
position. Treatment of phenol 6 with BTIB provided interme-
diate diene 8, which was then set to undergo [4 + 2] cycloaddition
with a range of dienophiles 9a–f present in the reaction mixture.
Alkenes 9a–d proved to be good dienophiles, and provided the
corresponding polycyclic structures 7 (R0 ¼ R0 0 ¼ H) as single
diastereomers in yields ranging from 50 to 89%. The diaster-
eoselectivity of the transformation is explained by attack of the
dienophile occurring from the less hindered oxygen-bearing face
of the diene.
Alkynes are also competent dienophiles but require higher
temperatures, and yields are lower than with their olefinic
counterparts. Electron-deficient dienes 8 (R ¼ I or Ac and
R ¼ R0 ¼ H) when reacted with electron-rich alkenes (9e–f) gave
excellent yields (from 74 to 91% yield) in this inverse-electron-
demand Diels–Alder reaction. Single diastereomers were
observed here also.
Finally, Wood et al. showed that this reaction proceeded with
good substrate-based control. Whilst a methyl group a to the
carboxylic acid 6 (R ¼ R0 ¼ Me and R00 ¼ H) provided little
stereo-induction, leading to a mixture of two diastereomers in
a 1 : 1 ratio, a methyl group at the b position 6 (R ¼ R0 0 ¼ Me
and R0 ¼ H) provided cycloadduct 7 as a single diastereomer.
Hypervalent iodine(III) has the advantage of using an environ-
mentally benign organo-oxidant, which is more efficient than
DDQ or ferric chloride.
Kita recently made an important breakthrough by perfecting
the first Wessely-type reaction using a catalytic amount of iodi-
ne(III)20 and subsequently by developing a chiral hypervalent
iodine(III) reagent for the enantioselective dearomatisation of
phenols.21 In the catalytic version the authors demonstrated that
hypervalent iodine(III) could be generated in situ from 4-iodo-
toluene (12) by using m-CPBA as a co-oxidant in presence of
triflic acid as an additive (Scheme 4). The intermediate 13
mediated the oxidation of phenols 10 into spiro-quinones 11with
concomitant regeneration of 4-iodotoluene 12 in yields ranging
from 66 to 91%. This versatile procedure was performed at room
Scheme 1
Scheme 2 Scheme 3
Fig. 2
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temperature and required only 0.05 equivalents of catalyst 12.
The authors did not mention the diastereoselectivity of the
reaction.
In further experiment, Kita et al. designed and synthesised
a recyclable catalyst 14 (Scheme 5). Its extraction from the
reaction mixture, in nearly quantitative yield, was facilitated by
its insolubility in methanol.
In the first example of its kind, Kita and co-workers have
designed and implemented a chiral iodine(III) oxidant for the
enantioselective formation of spirolactones. Chiral iodine(III)
reagent (R)-15, which has a rigid spirobiindane skeleton (Scheme
6), mediates the formation of ortho-spirolactone (+)-18 in high
yield (86%) with a significant level of enantioselectivity (86% ee).
Early studies also demonstrated that a catalytic version was
possible by using 30 mol% of chiral iodoarene (R)-16 and m-
CPBA as a co-oxidant in the presence of acetic acid; however, the
observed enantiomeric excess was significantly lower (69% ee).
In early 2010, Ishihara et al. developed a conformationally
flexibleC2-symmetric chiral iodoarene 19,
22which, upon reaction
with an oxidant, generated in situ the effective catalyst iodosy-
larene 20 (Scheme 7). The authors believed that a structural
chiral environment is imparted by either hydrogen-bonding (see
20a) or n–s* intramolecular interactions (see 20b).
Treatment of 1-naphthol derivatives 21 with precatalyst 19 (10
mol%) and m-CPBA (1.2–1.5 equiv) at 0 !C in a 2 : 1 mixture of
chloroform and nitromethane (Scheme 8) provided o-spi-
rolactones in good yield and enantiomeric excess (>83% ee).
The hypervalent iodine(III) phenolic dearomatisation strategy
has been applied with success to the synthesis of a range of
natural products including aranorosin (22a) (Fig. 3) or
(+)-scyphostatin (23) (vide infra), thereby illustrating the scope of
the method.
Aranorosin (22a) was isolated in 1988 from the fermentation
broth of the fungal strain Pseudoarachniotus roseus by Fehl-
haber, Mukhopadhyay and co-workers.23 This highly
Scheme 4
Scheme 5
Scheme 7
Scheme 8
Fig. 3
Scheme 6
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oxygenated tetracyclic compound incorporates seven stereo-
centres (five being contiguous) and two epoxides. Whilst the
relative stereochemistry for aranorosin has been established by
extensive NMR spectroscopic analysis together with chemical
degradation, the stereochemistry of the remote C-60 stereocentre
together with the absolute configuration remained undeter-
mined. Aranorosin exhibits antitumour and antifungal proper-
ties in addition to antibiotic activity against both Gram-positive
and Gram-negative bacteria,23a,c yeast and filamentous fungi (e.g.
MIC ¼ 1.5 mg mL"1 for Staphylococcus aureus, Bacillus subtilis
and Micrococcus luteus strains). Subsequently, fermentation of
the same fungal strain led to the isolation of four more metab-
olites: aranorisinols A and B (which were reduced at C-8 and C-2;
compare to 22a)24 and aranochlors A and B (monoepoxides).25
These compounds proved to be less active, therefore suggesting
that the bicyclic core plays a crucial role in the antifungal activity
of aronorosin. Accordingly a structure–activity relationship
carried out by Vijayakumar et al. concluded that the carbonyl at
C-8 and the bisoxirane moiety are essential for the antifungal
activity.26 Aranorosin has also been reported to inhibit the anti-
apoptotic functions regulated by Bcl-2.27
Three total syntheses28 have been reported, each of which has
used the same method to install the quaternary spiro stereocentre
i.e. an oxidative cyclisation. However, Rama Rao was the first to
use (in 1991) the phenolic dearomatisation as a key step to reach
the spirolactone backbone 24 contained in aranorosin (Scheme
9).29 Due to the chemical instability of the lactol natural product,
the authors chose to prepare the corresponding lactone 24. The
quaternary stereocentre was set up via the Wessely-type oxida-
tion of N-trifluoroacetyl-L-tyrosine 25 in the presence of BTIB
and pyridine in acetonitrile. Compound 26 was obtained in 60%
yield. Deprotection of the Boc group followed by the introduc-
tion of the side chain 27 and subsequent epoxidation provided
the bis-epoxide 24. Even though the NMR spectra were similar
to that reported for the natural compound 22a, the stereo-
chemistry at C-60 could not be firmly established due to the lack
of optical rotation data for the side chain.
En route to their total synthesis, both Wipf and McKillop
prepared the natural product and its C-60 epimer in order to be
able to assign its absolute configuration as R.
More recently, in a related example, Takagi and co-workers30
were able to take advantage of the diastereoselective formation
of the spiro quaternary centre during the phenolic
dearomatisation step leading to 28 in their total synthesis of
(+)-scyphostatin (23) (Scheme 10). This natural product was
isolated from a mycelial extract of Dasyscyphus mollissimus
SANK-13892, and displays the most potent and specific inhibi-
tory activity to sphingomyelinase (N-SMase) reported to date,
with an IC50 of 10 mM.
31 (+)-Scyphostatin 23 and its analogues
quickly attracted the attention of the synthetic community,32 and
hold significant potential as drug candidates for the treatment of
inflammatory, immunological and neurological disorders.
Structurally, (+)-scyphostatin consists of an oxygenated
cyclohexenone adorned with an epoxide and an unsaturated fatty
acid side chain bearing an amino alcohol. The tertiary alcohol at
C-4 was installed in an efficient manner through reductive
opening of the spirolactone 29, to provide the corresponding diol
30 in an excellent yield of 94%. According to Giannis and Pit-
sinos,32h the epoxycyclohexenone appears to be important for the
biological activity.
2.2 CAN oxidative coupling
In 2005,16 a publication featuring a cerium(IV)-mediated oxida-
tive coupling of 2,6-dibromophenol derivatives was reported by
Kobayashi. None of the classical oxidants usually used for
phenolic oxidation were able to deliver the expected compound
31 – reagents derived from iron(III), thallium(III) or lead(IV) led to
the degradation of the starting material. Hypervalent iodine(III)
BTIB gave only trace amounts of the desired adduct. However
cerium(IV) ammonium nitrate (CAN) in aqueous acetonitrile
afforded the desired cyclic carbamate in 53% yield (Scheme 11).
This domino reaction allowed the formation of two new C–O
Scheme 9
Scheme 10
Scheme 11
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single bonds concomitantly with the creation of a stereogenic
quaternary centre.
These different approaches illustrate the versatility of phenol
ring oxidation to the corresponding quinone in the synthesis of
complex molecules. Not only is the diastereoselectivity excellent
in many cases, but the conditions for hypervalent iodine(III) are
especially mild. Thanks to recent work from Kita, only a cata-
lytic amount of iodotoluene is sufficient to perform the reaction.
In addition, chiral hypervalent iodine(III) catalysts reported by
Ishihara and Kita are also available for the enantioselective
synthesis of these spiro compounds. However, this is only
applicable to the chemistry of phenol rings.
3 Reductive cross-coupling
Aparticularly attractivemethod for the formationof spirolactones
was independently reported by Fukuzawa33 and Inanaga,34
involving the samarium(II)-mediated reductive cross-coupling of
ketones with a,b-unsaturated esters, leading to lactones of type 34
(Scheme 12). This one-pot reaction effected rapid (1 min) forma-
tion of two single bonds and the creation of a quaternary stereo-
centre in high yields (95%), albeit withmodest diastereoselectivity.
Significant rate enhancement and improved diastereoselectivity
was observed with HMPA as co-solvent (entry 1).
This methodology was employed in the first synthesis of
lycoperdic acid (35) (Scheme 13),35 a non-proteinogenic a-amino
acid isolated in 1978 from the mushroom Lycoperdon perlatum.36
To date, no biological activity has been reported for this natural
product. However it is a glutamate derivative and was therefore
considered to be promising in the search for new biologically
active compounds targeting neurodegenerative disorders. The
structural features of lycoperdic acid were determined by both
chemical and spectroscopic methods. This five-membered
lactone incorporates a quaternary carbon a to the lactone
oxygen, which was introduced by the cross-coupling of ketone 36
with methyl acrylate. The corresponding spirolactone 37 was
obtained as a mixture of two diastereomers. Subsequent oxida-
tion provided the amides 38, which could be separated by flash
chromatography on silica gel. The major stereoisomer 38b
underwent a straightforward hydrolysis in acidic conditions to
provide the natural product 35. The quaternary centre thus
established corresponds to the fused stereocentre of the previous
spiro compound.
The scope of this reductive cross-coupling reaction was further
extended when Merlic developed an enantioselective version
employing enantiopure tricarbonylchromium–arene complexes
such as (S)-39.37 Treatment with 2.5 equivalents of samarium
iodide and 5 equivalents of methyl acrylate in the presence of
tert-butyl alcohol led to the endo-lactone complex (S,S)-40 in
81% yield, with 100% de and 100% ee (Scheme 14). The stereo-
control in this process derives from approach of the ester to the
ketyl radical anti to chromium. Decomplexation by treatment
with iodine provided the enantiopure spiro product (S)-41 in 61%
yield.
The authors were then able to access the alternative diaste-
reomer of chromium-spirolactone (S,R)-40 via a Lewis acid-
mediated cationic rearrangement. In presence of 0.5 equivalents
of BF3$Et2O in 1,2-dichloroethane for 1 min, the endo-lactone
complex underwent a ring-opening–ring-closing sequence via the
stabilised carbocation 42, leading to a mixture of exo- and endo-
lactone (S,R)-40 and (S,S)-40 in an 8 : 1 ratio. Decomplexation
of the major diastereomer (S,R)-40 provided the enantiopure
spiro product (R)-41 in 97% yield.
Thus, both possible spirolactone enantiomers can be accessed
from the same starting material. However, the nature of the
substrates is limited due to the requirement for an appended
benzene ring.
4 Radical-based approaches
Various radical initiators, e.g. TTMSH/AIBN and (Bu3Sn)2/hn,
have been used to synthesise spirolactones. However, all the
Scheme 12
Scheme 13
Scheme 14
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different methods rely on the same strategy, which consists of
radical-promoted formation of the five-membered lactone (the
appended ring at the spiro centre being established already).
A radical-mediated Michael addition was developed by Zhang
for the formation of benzospirolactones.38 Tris-
(trimethylsilyl)silane (TTMSH) and a catalytic amount of 2,20-
azobis(2-methylpropionitrile) (AIBN) as initiator were employed
to generate the aryl radical from 43 (X ¼ CH2), which then
underwent a smooth 5-exo cyclisation to generate spirolactones
44 in good yield (Scheme 15). This method is quite versatile and
tolerant of different substituents on the aryl moiety; similar
results were obtained with electron-withdrawing or electron-
donating substituents. However, the diastereoselectivity
observed is often poor. This approach was then extended to the
formation of spirodilactones (X¼O), spirolactone-lactams (X¼
NR) and spirolactone-thiolactones (X ¼ S) in similar yields.39
The methodology was exploited in a domino reaction leading
to bridged spirolactones after a double cyclisation (Scheme 16).40
Generation of the alkyl radical 45 from bromide 46 initiated a 5-
exo cyclisation onto the appended enone to provide a second
radical 47, which could then undergo a second 5-exo-trig cycli-
sation to generate the bridged lactone 48 in 78% yield as a 1 : 2
mixture of diastereomers (Scheme 16). Isolation of compound 48
suggested that the initial radical added onto the enone anti to the
allylic group 45. However, due to free rotation around the allylic
double bond the second cyclisation is less selective, explaining the
poor diastereoselectivity observed during this sequence. Despite
this, three new contiguous stereocentres were created, including
the spiro carbon along with two single bonds, making it a very
powerful process for building molecular complexity.
Larger ring sizes could also be accessed via this method. When
a methyl group is added to the double bond on the side chain (as
in 49 and 50), a 6-endo process occurred, affording 51 and 52 in
76 and 58% yield (respectively) as single isomers (Scheme 17).
16% of the product 53 arising from a single Michael addition was
also isolated.
Another method utilised hexabutylditin as the radical initi-
ator. Curran et al. have demonstrated formation of spirolactones
via a one-pot atom-transfer addition and annulation of iodo-
malonate 54 and methylenecyclohexane (55) in the presence of
a catalytic amount of hexabutylditin (10 mol%) under irradiation
(275 W sun-lamp).41 The reaction is thought to proceed via
intermediate 56 to afford the corresponding lactone 57 in 47%
yield, together with 25% of eliminated alkenes 58 (8 : 1 endo:exo)
(Scheme 18). During this process, several bonds were created
sequentially with concomitant formation of the fused quaternary
carbon.
5 Furanyl dienolate-based cyclisation
Access to spirolactones has also been achieved via the intra-
molecular alkylation (X ¼ I) or acylation (X ¼ imines or alde-
hydes) of furanyl dienolates of type 59 (Scheme 19). Once again,
this allows simultaneous generation of the quaternary spiro
centre and the ring appended to the lactone.
Unlike the classical esterification strategy to form spi-
rolactones bicyclic compounds, in Suginome’s approach, the
cycle appended to the lactone ring was formed last.42
5.1 Alkylation
g-Deprotonation of benzylic lactone 61 with LDA in HMPA/
THF generated the corresponding lithium anion, which
Scheme 15
Scheme 16
Scheme 17
Scheme 18
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underwent rapid 5- or 6-exo-tet alkylation to provide the spiro
products 62a and 62b in 67 and 59% respectively (Scheme 20).
This process has been extended by Mark!o to an intermolec-
ular, two-step approach to spirocyclic butenolides.43 First,
a ZnCl2-mediated condensation of 2-(trimethylsilyloxy)furan
(63) and orthoester iodides 64 gave the lactones 65 in 95 and 83%
yield respectively (Scheme 21). Further treatment with a base
produced the corresponding dienolate, which then underwent the
previously described intramolecular alkylation reaction to afford
the spirocyclic moieties 66 in good yield, whether the extra ring
was five- or six-membered. 2-(Trimethylsilyloxy)furan is thus
exploited as a dianion equivalent in this short and efficient
sequence.
5.2 Addition onto an imine (vinylogous Mannich)
The study of the vinylogous Mannich reaction for the formation
of spirolactones has been ably illustrated by the total synthesis of
rugolovasines A (67a) and B (67b), and croomine (68).
Isolation of rugulovasines A and B was first reported from
strains of Penicillium concavo-rugulosium44 and subsequently
from Penicillium islandicum,45 Penicillium biforme46 and Penicil-
lium variabile 1912.47 Rugolavasines A and B are members of the
ergot indole alkaloid family,48 which are characterised by the
unique spirolactone they contain (Scheme 22). The tetracyclic
structure of rugulovasine was proposed on the basis of chemical
evidence and crystallographic analysis.49 Interestingly, rugulo-
vasines A and B were isolated as racemates which interconverted
upon warming, presumably via a retro-vinylogous Mannich–
vinylogous Mannich process. This provided the inspiration for
Martin’s total synthesis.50 The furyl stannane 69 and the bromo
indole 70 were coupled and advanced to the key cyclisation
precursor 71. Reduction of the nitrile group of 71with DIBAL-H
afforded the intermediate imine 72, which upon treatment with
silica underwent the vinylogous intramolecular Mannich reac-
tion and provided the tetracyclic core of the rugolavasines, 73.
In a very similar fashion, the vinylogousMannich strategy was
applied to the synthesis of (+)-croomine and allowed the
formation of the seven-membered aza ring.51 (+)-Croomine,
which belongs to the Stemona alkaloid family, was isolated from
the roots and rhizomes of Croomia heterosepala in 1979,52 and
subsequently from Stemona tuberosa,53 Stemona japonica,54 and
Stichoneuros calcicola55 (Scheme 23). These plants have been
applied in traditional Chinese medicine for centuries for the
treatment of various respiratory diseases (bronchitis, pertussis
and tuberculosis), and to prevent attack by human and cattle
parasites, agricultural pests and domestic insects.56 The antitus-
sive profile of (+)-croomine was highlighted in 2008, and the
natural product was reported to exhibit dose-dependent inhibi-
tion of coughing (ID50 ¼ 0.18 mmol kg"1).57 Its structure and
relative and absolute stereochemistry was elucidated unambig-
uously on the basis of X-ray crystallographic analysis, and
chemical and spectral evidence.52 More recently, a biogenetic
origin of croomine was suggested and supported by the co-
isolation of pandanamine from Stichoneuros calcicola.55
(+)-Croomine is presumably formed by cyclisation of pandan-
amine (74).
Scheme 19
Scheme 20
Scheme 21
Scheme 22
Scheme 23
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5.3 Vinylogous aldol reaction
As part of the total synthesis of molecules from the family of the
stemonamides and the lambertellols, a vinylogous aldol reaction
was employed to form the quaternary spiro centre.
(a) Synthesis of (±)-stemonamide and (±)-isostemonamide.
(!)-Stemonamide (75a) and (!)-isostemonamide (75b), members
of the aforementioned structurally related family of Stemona
alkaloids, were isolated from the roots of Stemona japonica by
Xu and co-workers (Scheme 24).58 The densely functionalised
pyrrolo[1,2-a]azepine structure of these natural products was
elucidated by means of X-ray analysis and extensive NMR
spectroscopic analysis. In 2010, two stemonamide analogues
were identified that inhibited Pim-3 kinase activities (IC50 ¼ 78
mM for T-2/IC50¼ 92 mM for T-5). In addition, they inhibited the
cell proliferation of various cancer cell lines (human pancreatic,
hepatocellular and colon cancer) in vitro,59 and induced the
apoptosis of human pancreatic cancer cell lines in vitro (Fig. 4)60
These molecules could therefore be potential potent anticancer
drugs with apoptosis-inducing ability.
In 2001, Kende and co-workers reported the synthesis of ste-
monamide (75a) and its epimer isostemonamide (75b).61 Their
strategy suggested reaching the spirobicyclic butenolide 76 via an
intramolecular vinylogous aldol reaction from 77. The bicyclic
starting material necessary for this transformation comes from
an intermolecular vinylogous Mukaiyama aldol-type reaction
between the key subunits 78 and 79.
Oxidation of the primary alcohol 77 into aldehyde was per-
formed under Swern conditions. Next, treatment with DBU in
dichloromethane at room temperature overnight resulted in the
formation of the spiro quaternary centre as a 1 : 1 mixture of
diastereomers 76. Finally, the azepine ring 75 was formed via an
intramolecular nucleophilic displacement of mesylate in 70%
yield over three steps. Notably, the lack of diastereoselectivity
observed during the key spirocyclisation was advantageous, as
both epimers were required for the total synthesis of (!)-ste-
monamide (75a) and (!)-isostemonamide (75b).
(b) Synthesis of lambertellols. The tricyclic spirobutenolides
lambertellols A, B62 and C63 were isolated from the culture broth
of a congeneric fungus, Lambertella sp. 1346 (Fig. 5), and are
responsible for mycoparasitism on apple fruits.64 Structurally,
these three molecules present a spiro-1-furan-2-(5H) skeleton
which was established by extensive NMR spectroscopic methods.
The absolute stereochemistry of lambertellols A and B were
determined on the basis of CD spectra after chemical derivati-
zation. In contrast, lambertellol C was found to exist as a race-
mate. A biosynthetic pathway was suggested and supported by
the co-isolation of lambertellin and chrysophanol.63,64b From
a biological point of view, lambertellols A and B demonstrated
growth inhibition of spores of Cochlibolus miyabeanus (IC50 ¼
0.5 mg L#1) and were found to possess weak cytotoxicity against
P388 murine leukemia (IC50 ¼ 12 and 15 mg L#1 respectively).65
Hashimoto et al. exploited an intramolecular vinylogous aldol
reaction to form the spirobutenolide moiety.65 Accordingly,
methacrylation of 81 followed by ring-closing metathesis (RCM)
with Grubbs II catalyst conveniently provided the requisite
butenolide 82 (Scheme 25). The crucial aldol reaction ensued
upon treatment of aldehyde 82 with NaHMDS in DMF
at #40 $C, forming the lambertellol ring within 83a and its dia-
stereomer 83b in 77 and 13% yield respectively. Once again, both
diastereomers could be advanced to their respective natural
products lambertellol B and A after late-stage chemoselective
oxidations. Lambertellol C was obtained by simple oxidation of
the corresponding diol.
Scheme 24
Fig. 4
Fig. 5
Scheme 25
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Interestingly, employing the sterically congested butenolide 84
allowed adjustment of the diastereoselectivity of the reaction in
favour of diastereomer 85a (2.2 : 1 dr) (Scheme 26).
6 Cationic rearrangement
During the course of studies to delineate the biomimetic pathway
from dehydrocurdione 86 to curcumenol 87 and isocurcumenol
88, Kodama and Fukazawa showed that, whilst dehy-
drocurdione afforded curcumenol upon treatment with potas-
sium carbonate or alumina in benzene, when dehydrocurdione
was treated under acidic conditions, a 1 : 1 diastereomeric
mixture of spirolactone 89 was obtained quantitatively (Scheme
27).66 This interesting transformation presumably proceeds via
the described cationic intermediate 90 rather than the pericyclic
(Alder-ene) pathway to 87 and 88.
Another cationic rearrangement, this time involving an aryl-
nitrenium ion, has been highlighted. A solution of b-(4-azido-
phenyl)propanoic acid in trifluoroacetic acid at 0 !C was treated
with trifluoromethanesulfonic acid and allowed to stir at room
temperature for 25 h (Scheme 28).67 The spirodienone 92 resulted
from ipso-attack by the carboxy group para to the nitrenium ion,
but 92 was produced in a low yield of 20%.
Another method utilising allylic cations has also been
employed to generate spirolactones. Treatment of allylic alcohol
93 with hydrochloric acid provided the stabilised allylic carbo-
cation 94 (Scheme 29),68 which was trapped by the tethered
carbonyl group to provide the allylic spirolactone 95 in good
yield (67%).
7 Use of organometallic derivatives
In the following section, we provide an inventory of the reactions
that use organometallic species to access spirolactones. Three
main reactions have been reported in the literature: double
acylation using bis-metallated species, metal-mediated Refor-
matsky reaction, and processes involving carbonyl insertion.
7.1 Double acylation
Bis-metallated species have been exploited to form spirocyclic
molecules in a single step through annulation to a carbonyl
substrate. This is exemplified by Canonne strategy, which
consists of adding a bis-Grignard reagent 96 to a cyclic carbonyl
97.69 A double acylation took place on the same carbonyl of an
anhydride derivative, and afforded the corresponding spi-
rolactones 98 (Scheme 30). This strategy has the advantage of
flexibility over the bonds formed during the annulation process,
as exemplified by addition of lithium 3-lithiopropanoate to cyclic
ketone 99 (Scheme 31).
A related strategy reported by Santelli and co-workers70
involves the double Sakurai addition of 1,8-bis(trimethylsilyl)-
octa-1,6-diene 101 with succinic anhydride (Scheme 32), to
generate spirolactone 102 in good yield (80%). However, this
Scheme 26
Scheme 29
Scheme 28
Scheme 27
Scheme 30
Scheme 31
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procedure is less efficient with a,b-unsaturated anhydrides like
maleic or itaconic anhydride. Divinylspirolactones 102 have
proven to be useful in the synthesis of a number of natural and
non-natural steroids.70
7.2 Reformatsky-type reaction
A coupling reaction catalysed by SmI2/NiI2 and using b-pro-
piolactone (103) as the reactant has been described to provide
spirolactones of different size 104 (0 # n # 3) in good yields
(from 76 to 85% yield) (Scheme 33).71 During the course of this
reaction, samarium mediated the formation of a homoenolate
equivalent 106, which then reacted with a cycloalkanone. A
samarium-mediated spirocyclisation of cycloalkanones with
methyl 3-bromopropionate had already been reported by Csuk
seven years earlier,72 but the spirolactone product was isolated
only as a minor product of the reaction. Since then, several
groups have shown their interest in this transformation, and it
has been the subject of extensive publications: metallic Zn,73 Sn,74
and In75 derivatives have been reported to mediate reductive
cyclisation of bromomethyl acrylate derivatives 107 and cyclic
ketones 108 (Scheme 34). This Reformatsky-type reaction
provided spirolactones 109 exhibiting an exo double bond in
moderate (40% for SnCl2)
74 to good yield (82% for electro-
generated Zn*).73
Stereoselective spirolactone formation has been observed in
some cases. For example, addition of deoxyuloside 110 to (Z)-
ethyl 2-(bromomethyl)but-2-enoate and zinc–silver/graphite at
!30 "C for seven hours provided the spiro compound 111 in 74%
yield as a single diastereomer (Scheme 35).76 This could be
explained by the highly ordered chair-like transition state 112, in
which the re-face of the organozinc intermediate attacks the re-
face of the carbonyl moiety. The preference for equatorial attack
at the re-face of the carbonyl group over axial attack may be
explained by steric hindrance to si-face approach by the axial-
oriented anomeric methoxy group.
In a similar fashion, Trivedi has utilised a-hydroxy ketones to
effect a highly diastereoselective Reformatsky-type reaction
leading to spiro-a-methylene-g-butyrolactones (Scheme 36).77
Keto steroids incorporating an a-hydroxy subsituent 113b
afforded the corresponding spirocyclic molecule 114b as a single
diastereomer, whereas the same experiment onto a precursor
lacking this secondary alcohol function 113a led to a 70 : 30
diastereomeric mixture at the spirocentre of 114a. This obser-
vation was rationalised by a chelated transition state (Fig. 6) in
which the developing carbanion of the Reformatsky reagent
attacks from the re-face, the si-face being disfavoured due to
repulsion with the lone-pair of the oxygen of the hydroxyl group.
This Reformatsky-type methodology has been utilised for the
synthesis of sugar moieties substituted with an a-methylene-g-
lactone,78 and as a key step, in the total synthesis of stemospir-
onine (115) by Rauter and co-workers (Scheme 37).79
Stemospironine is another Stemona alkaloid that exhibits anti-
insecticidal properties, and was isolated from Stemona japonica
by Murakoshi and coworkers.80 Structurally, the 1-azabicy-
clo[5.3.0]decane nucleus is embedded in a complex tetracyclic
Scheme 32
Scheme 33
Scheme 34
Scheme 35
Scheme 36
Fig. 6
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scaffold. The relative and absolute configuration were estab-
lished unambiguously by X-ray crystallographic analysis and
spectroscopic methods.
The spirolactone 117 was obtained in 86% yield with complete
facial selectivity after treatment of bicyclic compound 116 with
ethyl bromomethylacrylate and zinc dust in THF.
7.3 Carbonyl insertion
(a) Mg–CO2. Rieke and co-workers have utilised a one-pot
sequence in which magnesium metallocycle 119 reacted with
ketones at !78 "C (Scheme 38). The corresponding 1,2-addition
adduct 120 then reacted with carbon dioxide, leading to the
introduction of the carbonyl group contained in the final lactone.
The subsequent lactonisation provided the desired spirocyclic
molecule 122 in good yields (from 59 to 68% depending on the
nature of the ketone).81
(b) Nickel-catalysed alkoxycarbonylation. Ogoshi and co-
workers have exploited the formation of a [4.3]spirolactone
starting from a nickel complex.82 Oxidative cyclisation of 1,3-
butadiene and cyclobutanone mediated by a nickel catalyst led to
the formation of an h3:h1-allylalkoxynickel complex 125 (Scheme
39). The latter, upon treatment with carbon monoxide, provided
the spiro molecule 126 in 38% yield.
8 Halolactonisation
Spiro-g-butyrolactones may also be obtained in excellent yield
via halolactonisation of enol lactones such as 127 (Scheme 40).83
This transformation presumably proceeds via the intermediate
bromonium ion 129 and bromo acid 130.
A similar strategy was adopted by Wawrze!nczyk, who used
iodine andN-bromosuccinimide on limonene and carane systems
respectively.84 Larock et al. formed the iodonium 132 on a triple
bond with ICl and therefore obtained the corresponding bute-
nolide 133 in a quantitative manner via an ipso-halocyclisation
(Scheme 41).85 This same reaction may also be promoted by CuX
(X ¼ I, Br, SCN) and a source of electrophilic fluoride, which
produced the spirobutenolide in 45% yield.86
Finally, Piva et al. obtained the butyrolactone 135 in 69% yield
through treatment of ethyl 3-cyclobutylprop-2-enoate 134 with
in situ-generated TMSI (Scheme 42).87 Dihydroxylation of 134
also provided directly the parent b-hydroxylactone 136 in 69%
yield.
9 Pericyclic-type reactions
Pericyclic reactions are without doubt amongst the most
powerful of synthetic tools and often offer a high degree of
selectivity in both their inter- or intramolecular versions. A
further advantage they offer is often providing access to signifi-
cant complexity from relatively simple precursors. As will be
discussed, pericyclic reactions have allowed a convergent, ster-
eoselective and efficient approaches to the spirocyclic molecules,
compounds targeted in this review. Here the term pericyclic is
Scheme 37
Scheme 38
Scheme 39
Scheme 40
Scheme 41
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used loosely to describe those reactions which appear to have
arisen through a formal pericyclic process, although mechanis-
tically this may not always be the case.
9.1 Electrocyclisation
Access to [4.2]spirolactone 137 was achieved by thermal rear-
rangement of diazo ketone 138.88 Upon brief heating in refluxing
benzene, a Wolff rearrangement occurred, leading to the inter-
mediate ketene 139 (Scheme 43). This stereoselectively provided
the spiro compound 137 as a single diastereomer in 50% yield via
a hypothetical ordered dipolar cyclic transition state. This is
a rare example of the formation of [4.2]spirolactones.
9.2 [2 + 1] photocycloaddition
In 1995, Tomioka reported another route to this rare [4.2]spi-
rolactone structure.89 Irradiation of a solution of benzocyclo-
butenedione with C60 in toluene provided spiro C60 monoadduct
in 35% yield, along with multiadducts and C60 starting material
(55%) (Scheme 44).
9.3 [2 + 2] cycloaddition
Several cases of dimerisation of alkylidenebutenolides have been
reported in the literature, either under photolytic90 or thermal
conditions.91 When acetoxy furanone 142 was heated in
a mixture of acetic acid and anhydride acetic with a catalytic
amount of sulfuric acid, the corresponding methylene furanone
protoanemonin (143) was formed, which immediately dimerised
to the natural product anemonin 14492 in 53% yield (Scheme
45).91
Upon irradiation with a mercury lamp, the bioactive
secondary metabolite (Z)-ligustilide 145 underwent dimerisation,
leading to four different products. The natural product riligus-
tilide 146 and three other phthalides 147a–cwere isolated in 7, 18,
11 and 7% yields, respectively (Scheme 46).
More recently, Sulikowski et al. reported the utilisation of the
intramolecular [2 + 2] photocycloaddition in their studies
directed towards the total synthesis of bielschowskysin (148)
(Scheme 47).90b This natural product was isolated in 2004 from
Pseudopterogorgia kallos and exhibits valuable biological activ-
ities, including strong in vitro cytotoxicity against the EKVX
non-small-cell lung cancer (GI50 < 0.01 mM) and CAK-1 renal
cancer cell lines (GI50 ¼ 0.51 mM), as well as antiplasmodial
activity against drug-resistant strains of the malaria-causing
protozoan parasite, Plasmodium falciparum (IC50 ¼ 10 mg
mL"1).93 This highly oxygenated hexacyclic diterpene contains
eleven stereocentres and an unusual [4.3]spirolactol moiety.
Irradiation of a solution of 149a in acetone first led to the iso-
merisation of 149a, therefore providing a mixture of geometric
isomers of the starting material 149a and 149b. Further irradia-
tion resulted in the conversion of both isomers, providing the
tetracyclic core 150 of the target compound in 50% yield as
a mixture of two diastereomers in a 5 : 1 ratio.
9.4 Diels–Alder reaction
The Diels–Alder reaction has been used as a powerful tool to
generate quaternary stereogenic centres, and in this regard spi-
rolactones are no exception.
(a) Methodology. Participation of the exocyclic double bond of
an alkylidene butenolide as a 2p partner in an intermolecular
Diels–Alder reaction was initially reported by Font in 1986
(Scheme 48).94 Upon heating for 20 h at 210 #C in the presence of
hydroquinone and a large excess of butadiene, compound 151
cyclised to the fused six-membered ring 152 in 53% yield but
Scheme 42
Scheme 43
Scheme 44
Scheme 45
Scheme 46
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a side reaction was also noticed. Under the conditions of the
reaction, butenolide 151 first eliminated to the corresponding
protoanemonin 143. The latter then underwent the [4 + 2] reac-
tion at the exocyclic double bond, leading to spiro adduct 153 in
25% yield.
Subsequently, Poss et al. prepared dienophile 154 from
L-ascorbic acid, and found that in the presence of various dienes
Diels–Alder reactions occurred chemoselectively on the exocyclic
double bond of the butenolide (Scheme 49).95 After stirring the
two partners 154 and 155 in THF at 125 !C for three days the
spirocyclic adduct 156 was isolated in 54% yield as a single
regioisomer. However no exo/endo preference was observed, as
evidenced by the diastereomers being isolated in a 1 : 1 ratio.
Similar conclusions were independently reached by Yoshii.96
From 1990 to 1997 Font and Ortu~no carried out extensive
research in order to highlight and understand the factors gov-
erning the regio-, chemo- and stereoselectivity of this reaction.97
The nature of the diene (open-chain C-substituted, hetero-
substituted, cyclic and asymmetric dienes), dienophile and reac-
tion conditions were studied and theoretical calculations and
mechanism investigations were performed.
The dienophile alkylidene butenolide, being a conjugated
lactone but also an enol lactone, is a complex captodative system
of activation. Theoretical calculations using MNDO and AM1
semi-empirical methods concluded that the frontier orbital
theory failed to predict the chemoselectivity of the trans-
formation, and the authors therefore suggested an asynchronous
pathway through a biradicaloid transition state.97a Cyclobutane
derivatives, detected at the initial stage of the reaction, supported
this biradical mechanism (Scheme 50).97e The authors synthesised
cyclobutane 157 under photochemical conditions, and this, upon
heating to 150 !C, furnished the corresponding [4 + 2] cyclo-
adduct 153, thus demonstrating that cyclobutane species were
intermediates in the formation of the six-membered ring spi-
rolactones.
The synthesis of optically active spiro[4,5]decanes 159 (which
are building blocks found in many products of biological
importance) via chiral-auxiliary-mediated [4 + 2] reactions has
been demonstrated.98 Three different dienes bearing optically
active auxiliary groups 158 (R* ¼ (#)-menthyl, (#)-bornyl or
(+)-isocampheyl) were reacted with protoanemonin 143 in
a sealed tube between 120 and 140 !C for 14 to 18 h in
dichloromethane (Scheme 51). Asymmetric induction was
observed but, in all cases, four different diastereomers were
obtained. However, the diastereofacial selectivity, especially for
the (#)-bornyl substituted diene, was reasonable (endo:exo ¼
28 : 72).
(b) Synthesis of ircinianin. (#)-Ircinianin (160)99 and its cyclic
isomer (+)-wistarin (161)100 are unique cyclic fur-
anosesterpenetetronic acids (Fig. 7) isolated from the marine
sponge Ircinia wistarii. The structures of these unique molecules
were elucidated by X-ray crystallographic analysis (for (#)-irci-
nianin only) and NMR spectroscopic analysis, although the
absolute configurations remained unclear at the time. Uenishi
has demonstrated that perchloric acid promoted the cyclisation
of (#)-ircinianin to (+)-wistarin, therefore highlighting the
possible biomimetic pathway to (+)-wistarin.101
Yoshii achieved the first total synthesis of racemic ircinianin in
1986.102 The key step to form the (5,6,5) core including the spiro
quaternary stereocentre involved a biomimetic thermal intra-
molecular [4 + 2] reaction (Scheme 52). Accordingly, tetraene
162 was heated in boiling benzene and afforded ($)-ircinianin in
71% yield as a single diastereomer.
A decade later, as part of a project devoted to the determi-
nation of the absolute configuration of these interesting natural
Scheme 48
Scheme 49
Scheme 50
Scheme 47
Scheme 51
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products, Uenishi et al. developed an enantioselective approach
and achieved the first asymmetric total synthesis of (!)-ircinia-
nin.103 Their synthetic strategy is outlined in Scheme 53 and relies
on the same biomimetic intramolecular Diels–Alder key step as
Yoshii. They envisaged that the fully elaborated precursor 163
might be formed by means of a Nozaki–Hiyama–Kishi–Takai
reaction (NHKT) between the two subunits 164 and 165.
Surprisingly, when a solution of compounds 164 and 165 in
DMSO were treated with NiCl2/CrCl2 for 18 h, the isomer 163b
(OH ¼ b) resulting from the NHKT coupling was obtained in
20% yield, along with 60% of the cycloadduct resulting from the
Diels–Alder reaction, 166a (Scheme 54). It is noteworthy that the
tricyclic structure 166a was obtained as a single diastereomer.
From these experimental results, several conclusions could be
made. The chromium(II) chloride probably acts as a Lewis acid
catalysing the [4 + 2] reaction and the Ni/Cr-mediated coupling
certainly occurred prior to cyclisation. In addition, the fact that
the trans-fused product 163a was preferred over the cis-fused
product indicates that Ia is the most likely transition-state
(Scheme 55). This last observation might explain why 163b failed
to give the Diels–Alder cycloadduct 166b under the mild reaction
conditions. If we assume, by analogy with 163a, that Ib is the
most likely transition state, to overcome the steric interaction
between the Me group of the diene and the hydroxyl group
harsher reaction conditions are required.
In conclusion, the first enantioselective synthesis of (!)-irci-
nianin and (+)-wistarin has been accomplished featuring the
construction of the quaternary spiro centre by a domino reaction
involving a metal-mediated coupling followed by a Diels–Alder
reaction. The absolute configuration of ircinianin and wistarin
has therefore unambiguously been assigned.
(c) Synthesis of abyssomicin.Abyssomicin C (167a), isolated by
S€ussmuth in 20043 from a marine actinomycete, Verrucosispora
strain AB18-032, and found to possess significant levels of anti-
microbial activity against a variety of Gram-positive bacteria,
especially against Staphylococcus aureus strains (MIC against
methicillin-resistant S. aureus ¼ 4 mg mL!1) and drug-resistant
strains (MIC against vancomycin-resistant S. aureus¼ 13 mg
mL!1) (Fig. 8). Its antibiotic activity is mediated through inhi-
bition of the p-aminobenzoic acid pathway. Its chemical struc-
ture was determined by comprehensive NMR and MS
spectroscopic analysis, and revealed a unique oxabicy-
clo[2.2.2]octane subunit, a tetronate moiety and an 11-membered
ring bearing an enone with an E-configured alkene.The stereo-
chemistry of abyssomicin C was assigned as shown in structure
167a. The co-isolation of inactive compounds abyssomicin B
(167b) and D (167c), lacking the E-olefin, with abyssomicin C
suggested that the enone might serve as a Michael acceptor in
both the mechanism of action and the biogenesis of abyssomicin
B and D.
Because of its intriguing and unusual structural features
combined with unique biological activities, abyssomicin C
Fig. 7
Scheme 52
Scheme 53
Scheme 54
Scheme 55
Fig. 8
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quickly became an attractive challenge for the worldwide
synthetic community.104 To date, only two total syntheses105 and
two formal ones have been published.106 The first total synthesis
of abyssomicin was reported in 2005 by Sorensen and his co-
workers.105a Their strategy is based on a biomimetic intra-
molecular Diels–Alder reaction of linear precursor 168.
The trienone 168 was generated from the b-elimination of 169
upon exposure to scandium(III) triflate (Scheme 56). The result-
ing Diels–Alder precursor 168 proved to be unstable, but suc-
ceeded in giving the desired cycloadduct 170 when a solution of
the trienone 168 in toluene was heated to 100 !C for four hours.
The authors elegantly managed to overcome this problem of
stability by developing a one-pot domino process (elimination
and [4 + 2] cycloaddition) starting from compound 169.
Accordingly, the tricyclic structure 170 was generated in one step
from diene 169 in presence of the Lewis acid lanthanum(III) tri-
flate. Both methods were highly diastereoselective and allowed
them to build the spiro quaternary stereocentre. No other
regioisomeric cycloadducts were detected. This excellent dia-
stereoselectivity has been rationalised by the authors after
calculation of the energies of the different possible transition
states. It was concluded that the lowest-energy transition-state
conformation resembled II, where the two carbonyl groups
adopt an anti relationship.
This asymmetric synthesis of abyssomicin proceeded in fifteen
steps (for the longest linear sequence). Notably, the biomimetic
intramolecular diastereoselective Diels–Alder step was also used
by Snider106a and Couladoros106b as a part of their formal
syntheses of abyssomicin.
(d) Synthesis of tokinolide B. Levistolide A (171) and tokino-
lide B (172), which were isolated from the rhizome of Ligusticum
and Cnidium species, are active constituents of traditional
Chinese herbal medicine (Scheme 57).107 These dimers of ligu-
stilide 145 have been reported to display potent vasodilatory
activity depending predominantly on their Ca2+-channel blocker
properties.107e In addition, levistolide A has been shown to
overcome P-glycoprotein-mediated drug resistance in human
breast carcinoma cells.108 From a structural point of view, these
two pentacyclic structures have four stereocentres each and are
found as racemates in Nature. To date, only one total synthesis
of these two natural products has been reported.109 Wakamatsu
et al. strategy employed a Diels–Alder reaction to access both
dimers 171 and 172. Accordingly, a solution of ligustilide 145110
in benzene was heated to reflux and afforded 2 and 4% of endo
adducts 171 and 172 respectively, along with 56% of the starting
material. Despite the use of Lewis acids or high-pressure condi-
tions, the reaction still proceeded in low yield. When the
temperature of the reaction mixture was raised to 200 !C, 23% of
dimer 171 along with 60% of starting material were obtained.
From these results, it was deduced that the high recovery of
starting material was the result of the competing retro-Diels–
Alder reaction, that the endo approach was preferred due to
secondary orbital interactions, and finally that 172was converted
to the thermodynamically more stable compound 171.
(e) Synthesis of deoxy-lambertellols. Very recently, Commeiras
and Parrain111 have reported an efficient synthesis of deoxy-
lambertellols 173 via a highly chemo- and diastereoselective
intermolecular Diels–Alder cycloaddition between trans-1,2-
disiloxybenzocyclobutenes 174 and 2-methylprotoanemonine
175 (Scheme 58). At 50 !C in degassed benzene, [4 + 2] cyclo-
addition of 174 and 175 occurred within four hours, affording
chemoselectively the desired spirolactone 176 with complete
endo-stereoselectivity in 87% yield. With the carbon skeleton of
lambertellols in hand, the authors carried on the synthesis to the
simplified deoxy-lambertellols C and B 173.
Scheme 56 Scheme 58
Scheme 57
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9.5 [3 + 2]-type cyclisation
In 1997, Nair reported a new route to spirolactones via a tri-
phenylphosphine-mediated-[3 + 2] cyclisation between dimethy-
lacetylene dicarboxylate and either 1,2- or 1,4-benzoquinone 177
(Scheme 59).112 During the course of this reaction, a catalytic
amount of phosphine (50 mol%) first adds to the alkynone in
a 1,4-fashion. The resulting zwitterionic species 178 then adds
onto one of the two ketones present on 177. Finally, cyclisation
of intermediate 179 followed by elimination of the phosphine
provides the spirolactone incorporating a ketone a (or g if 1,4-
benzoquinone is used) to the fused quaternary carbon 182. Only
one step was required to access bicyclic compound starting from
readily available and simple starting materials. However, the
limitation of the method lies in the exclusive use of DMAD. A
few years later, Esmaili and Bodaghi used the same procedure for
the addition of dimethylacetylene dicarboxylate to istatin
derivatives.113
The cycloaddition strategy allows rapid access to complex
polycyclic structures, especially in the intramolecular version of
the Diels–Alder reaction. One limitation of this approach can be
the instability of the diene employed. On the other hand, if these
dienes are easily accessible, the chemist has at their disposal
a powerful synthetic tool for the synthesis of the corresponding
spiro compounds.
10 Miscellaneous
10.1 1,6-Addition
Reaction of protoanemonin 143 and a dimethyl malonate anion
led to the formation of two spiro molecules 183 and 184 in 22 and
17% respectively via consecutive 1,6-additions (Scheme 60).114
10.2 Dyotropic rearrangement
Having a spiro butyrolactone regioselectively substituted at the
a carbon of the lactone ring presents a challenge from a synthetic
point of view. Black et al. reported a sequence in only three steps
starting from readily available starting materials to reach effi-
ciently a-substituted spiro butyrolactone 185 (Scheme 61).115
This methodology is based on a stereoselective dyotropic rear-
rangement. During this process, two s-bonds simultaneously
migrate intramolecularly. The concerted nature of this trans-
formation requires an antiperiplanar alignment of the migrating
bonds and hydride migrate preferentially compared to carbon.
In a typical procedure a solution of propiolactone derivative
186 in diethyl ether was treated with one equivalent of magne-
sium bromide etherate for six hours and the corresponding
bicyclic molecule fused at a central carbon was obtained in
excellent yield and with complete retention of the stereochem-
istry.
This expedient hydride transformation in which a ring
expansion of b-lactone was accompanied by migration provides
easy access to a-substituted spiro butyrolactones. However, this
method is limited to appended six-membered rings. The migra-
tory aptitude is also dependent on energetic factors, such as the
release of strain in a pendant cycloalkyl ring, and no spiro
compound was detected with a five-membered ring; instead, the
fused spirobutyrolactone was isolated.
11 Conclusion
Various methods for the synthesis of spirolactones concomi-
tantly with the quaternary stereocentre have been discussed.
They provide rapid entry into a diverse range of highly relevant
(natural and/or biologically defined targets) and sterically con-
strained architectures, and ones for which the quaternary centre
is often implicated in the bioactivity of the natural product.
These methods are also often accompanied by high diaster-
eoselectivities, especially in their intramolecular versions.
However, a lack of general enantioselective approaches remains,
and this area is still in its infancy. This has been partly solved in
the case of phenolic oxidation to quinones by the development of
an asymmetric catalyst by Kita and Ishihara, although this
method is unfortunately limited to this type of substrate. The
development of a suitable chiral catalyst for the cycloaddition
reactions could lead to general enantioselective approaches toScheme 59
Scheme 60
Scheme 61
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spirolactones. Finally, it would be interesting, from a structure–
activity relationship point of view, to understand the role played
by the strained spiro-structure when compared to the corre-
sponding tertiary alcohol.
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